We believe that whether one smokes for purpose or for pleasure; health and happy experiences are important to us. We are boutique batch growers of artisan strains and our genetics have withstood the test of time as terpene rich and naturally resistant. We rely on environmental controls and biological solutions for pest and mold management then scientifically test for contaminants because everyone’s health matters. #BEHAPPY!
Shawn DeNae Wagenseller, Washington Bud Company CEO
Washington Bud Company
Sponsor (Vegetative)
Donor
Information Set
- No information available at this time
Observations
WSLCB - Board Meeting
(September 15, 2021) - Summary
The board began rescinding unnecessary interim policies, heard rulemaking updates, and a licensee called for more time to transition from seed-to-sale traceability to weekly reporting.
WSLCB - Board Meeting
(July 7, 2021) - Synthesized Cannabinoids
Board members voted to restart rulemaking on synthesized cannabinoids and heard directly from two advocates for the practice amongst many more otherwise opposed.
WSLCB - Board Meeting
(April 14, 2021) - Summary
In addition to a rulemaking review, the meeting featured several public comments from cannabis farmers concerned about the impact cannabinoids derived from hemp CBD were having in the state’s cannabis market.
WA House FIN - Committee Meeting
(March 16, 2021) - SB 5004 - Public Hearing
Testimony on legislation establishing a limited excise tax exemption for medical cannabis patients registered with the State painted an encouraging picture of potential impacts for patients and the regulated industry.
WA Senate LAW - Committee Meeting
(March 16, 2021) - HB 1105 - Public Hearing
The second policy committee hearing on legislation extending arrest protections to all authorized medical cannabis patients elicited similar testimony and substantial sign in support.
WA House APP - Committee Meeting
(February 9, 2021) - HB 1019 - Public Hearing
Testimony in the fiscal committee hearing on cannabis home grow was mostly positive with over one hundred people signed in support, while a small group voiced concerns about youth access and normalization.
WSLCB - Board Meeting
(February 3, 2021) - Summary
No one showed up to testify on proposed rules to implement HB 2826, but two public comments addressed hemp biomass in the 502 market and an upcoming deliberative dialogue session.
WA Senate LCTA - Committee Meeting
(February 1, 2021) - SB 5365 - Public Hearing
- USA - Washington
- Washington State Senate Labor, Commerce, and Tribal Affairs Committee (WA Senate LCTA)
A diverse majority publicly testified against legislation to establish a Washington state cannabis commodity commission, although more individuals signed in support.
WSLCB - Special Board Meeting
(November 18, 2020) - Summary
The WSLCB Board and Policy and Rules team heard strong criticisms of the supplemental Quality Control Testing and Product Requirements rule proposal from many stakeholders.
WSLCB - Board Meeting
(October 28, 2020) - Summary
The WSLCB moved forward with a CR-102 proposing the establishment of Location Compliance Certificates; heard public comments on youth drug prevention and quality control (QC) testing; and confirmed the agency will only have one board meeting in November.